Highbridge Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Highbridge Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$12K	–	467
2018 Q4	$12K	Buy	+100,000	New	+$65.6K	﹤0.01%	349
2017 Q2	–	Sell	-62,106	Closed	-$289K	–	1809
2017 Q1	$289K	Buy	62,106 +10,267	+20%	+$59.5K	﹤0.01%	1157
2016 Q4	$316K	Sell	51,839 -26,738	-34%	-$140K	0.01%	958
2016 Q3	$433K	Buy	+78,577	New	+$368K	0.01%	849
2016 Q2	–	Sell	-398,228	Closed	-$1.1M	–	1936
2016 Q1	$1.1M	Buy	398,228 +60,214	+18%	+$218K	0.02%	702
2015 Q4	$1.92M	Hold	338,014	–	–	0.03%	539
2015 Q3	$1.79M	Buy	+338,014	New	+$2.62M	0.03%	579
2014 Q3	–	Sell	-244,884	Closed	-$997K	–	1453
2014 Q2	$997K	Buy	+244,884	New	+$1.04M	0.01%	569
2013 Q4	–	Sell	-18,263	Closed	-$82K	–	1441
2013 Q3	$82K	Buy	+18,263	New	+$81.9K	﹤0.01%	1223

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Highbridge Capital Management's SGYP Position: Q1 2019 in Review

Highbridge Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 100,000 shares — an estimated $12K sold.

Highbridge Capital Management first reported a position in SGYP in Q3 2013 and held it in 9 quarters. The position peaked at $1.92M in Q4 2015. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Highbridge Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Highbridge Capital Management sold 100,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $12K.
Highbridge Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 9 quarters.
Highbridge Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.92M in Q4 2015.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Highbridge Capital Management's 13F filing for Q1 2019, filed 15 May 2019.